|
Volumn 17, Issue 5, 2003, Pages
|
Adjuvant therapy in gastric cancer: can we prevent recurrences?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADENOCARCINOMA;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
CANCER STAGING;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
FEMALE;
GASTRECTOMY;
HUMAN;
IMMUNOTHERAPY;
MALE;
METHODOLOGY;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NEEDLE BIOPSY;
PATHOLOGY;
PROGNOSIS;
RADIATION DOSE;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK ASSESSMENT;
STOMACH TUMOR;
SURVIVAL RATE;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
ADENOCARCINOMA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOPSY, NEEDLE;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
FEMALE;
GASTRECTOMY;
HUMANS;
IMMUNOTHERAPY;
MALE;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PROGNOSIS;
RADIOTHERAPY DOSAGE;
RADIOTHERAPY, ADJUVANT;
RANDOMIZED CONTROLLED TRIALS;
RISK ASSESSMENT;
STOMACH NEOPLASMS;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0141610993
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (21)
|
References (58)
|